Zentalis Pharmaceuticals, Inc. revenue breakdown overview

Zentalis Pharmaceuticals, Inc. revenue for the last year amounted to 67.42 M USD, the most of which — 67.42 M USD — came from its highest performing source at the moment, Novel Small Molecule Therapeutics, the year earlier bringing 13.92 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Zentalis Pharmaceuticals, Inc. 67.42 M USD, and the year before that — 13.92 k USD.